From: Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients
Characteristic | All patients N = 213 | Normoglycemia N = 54 | Prediabetes N = 48 | Diabetes N = 111 | p value |
---|---|---|---|---|---|
Age; year | 57.4 ± 15.3 | 53.2 ± 16.8B | 55.6 ± 15.7AB | 60.4 ± 13.7A | 0.01 |
Gender | |||||
Male | 184 (86.4) | 47 (87.0) | 43 (89.6) | 94 (84.7) | 0.701 |
Female | 29 (13.6) | 7 (13.0) | 5 (10.4) | 17 (15.3) | |
BMI | |||||
Normal-weight | 43 (20.2) | 12 (22.2) | 7 (14.6) | 24 (21.6) | 0.544 |
Overweight/obese | 170 (79.8) | 42 (77.8) | 41 (85.4) | 87 (78.4) | |
Blood group | |||||
O | 80 (37.6) | 23 (42.6) | 15 (31.3) | 43 (38.7) | 0.587 |
A | 67 (31.5) | 15 (27.8) | 15 (31.3) | 36 (32.4) | |
B | 46 (21.6) | 12 (22.2) | 10 (20.8) | 24 (21.6) | |
AB | 20 (9.4) | 4 (7.4) | 8 (16.7) | 8 (7.2) | |
Rh | |||||
Negative | 36 (16.9) | 10 (18.5) | 6 (12.5) | 20 (18.0) | 0.650 |
Positive | 177 (83.1) | 44 (81.5) | 42 (87.5) | 91 (82.0) | |
Hb | 14.2 ± 8.0 | 15.0 ± 13.5 | 13.6 ± 2.2 | 13.9 ± 2.8 | 0.638 |
PLT | 271.3 ± 133.2 | 243.6 ± 100.4B | 314.6 ± 131.6A | 262.2 ± 152.1AB | 0.026 |
WBC | 13.9 ± 7.3 | 13.3 ± 6.8 | 15.5 ± 9.8 | 13.4 ± 6.1 | 0.190 |
ESR | 58.8 ± 29.1 | 55.3 ± 30.5 | 60.5 ± 29.0 | 60.5 ± 28.2 | 0.562 |
RBG | 269.5 ± 179.4 | 109.1 ± 23.7C | 167.6 ± 19.0B | 391.6 ± 170.6A | < 0.001 |
ALT | 54.9 ± 47.8 | 44.9 ± 37.1 | 64.5 ± 61.0 | 52.9 ± 37.1 | 0.103 |
AST | 41.9 ± 22.0 | 40.7 ± 20.2 | 43.4 ± 19.2 | 41.0 ± 25.2 | 0.799 |
ALP | 98.8 ± 70.9 | 90.4 ± 39.6AB | 84.3 ± 59.4B | 116.1 ± 92.8A | 0.041 |
CHOL | 181.2 ± 87.2 | 165.5 ± 61.0 | 180.0 ± 93.4 | 192.9 ± 100.1 | 0.243 |
TRIG | 200.3 ± 118.9 | 189.7 ± 119.9 | 211.2 ± 119.7 | 198.6 ± 118.3 | 0.676 |
SCr | 1.7 ± 5.4 | 1.7 ± 5.5 | 1.1 ± 0.7 | 2.0 ± 7.0 | 0.670 |
BUN | 63.7 ± 66.3 | 54.0 ± 31.9 | 59.1 ± 42.8 | 75.1 ± 94.9 | 0.205 |